Jump To Section:

Identification Taxonomy Ontology Physical properties Spectra Biological properties Concentrations Links References XML

Record Information

Version

5.0

Status

Detected and Quantified

Creation Date

2012-09-11 17:47:30 UTC

Update Date

2023-05-30 20:56:03 UTC

HMDB ID

HMDB0032055

Secondary Accession Numbers

HMDB32055

Metabolite Identification

Common Name

N-Acetylhistidine

Description

N-Acetyl-L-histidine or N-Acetylhistidine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Acetylhistidine can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetylhistidine is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-histidine. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618 ). About 85% of all human proteins and 68% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686 ). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT‚Äôs (PMID: 30054468 ). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468 ). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetylhistidine can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618 ). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free histidine can also occur. In particular, N-Acetylhistidine can be biosynthesized from L-histidine and acetyl-CoA by the enzyme histidine N-acetyltransferase (EC 2.3.1.33). Many N-acetylamino acids are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986 ; PMID: 20613759 ). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557 ).

Structure

MOL 3D MOL SDF 3D SDF PDB 3D PDB SMILES InChI


  Mrv1652303062020422D          

 14 14  0  0  0  0            999 V2000
10000.673310000.4125    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
 9999.958810000.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10000.6733 9999.5884    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
10001.3871 9999.1748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10002.1029 9999.5884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10001.3871 9998.3496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10001.387110000.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10002.102910000.4125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10001.387110001.6503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 9998.572510000.9075    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 9997.905110000.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 9998.1600 9999.6379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 9998.9850 9999.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 9999.239910000.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  1  0  0  0
  1  7  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  2  0  0  0  0
  7  8  1  0  0  0  0
  7  9  2  0  0  0  0
 13 14  2  0  0  0  0
 10 11  2  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
  2 14  1  0  0  0  0
M  END
> <DATABASE_ID>
HMDB0032055

> <DATABASE_NAME>
hmdb

> <SMILES>
CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O

> <INCHI_IDENTIFIER>
InChI=1S/C8H11N3O3/c1-5(12)11-7(8(13)14)2-6-3-9-4-10-6/h3-4,7H,2H2,1H3,(H,9,10)(H,11,12)(H,13,14)/t7-/m0/s1

> <INCHI_KEY>
KBOJOGQFRVVWBH-ZETCQYMHSA-N

> <FORMULA>
C8H11N3O3

> <MOLECULAR_WEIGHT>
197.194

> <EXACT_MASS>
197.080041226

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_ATOM_COUNT>
25

> <JCHEM_AVERAGE_POLARIZABILITY>
18.818443361938435

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
3

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(2S)-2-acetamido-3-(1H-imidazol-4-yl)propanoic acid

> <ALOGPS_LOGP>
-0.34

> <JCHEM_LOGP>
-2.4723116491473176

> <ALOGPS_LOGS>
-1.51

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
-1

> <JCHEM_PKA>
13.008634104959125

> <JCHEM_PKA_STRONGEST_ACIDIC>
3.525509458774198

> <JCHEM_PKA_STRONGEST_BASIC>
6.5517717993458024

> <JCHEM_POLAR_SURFACE_AREA>
95.08000000000001

> <JCHEM_REFRACTIVITY>
46.9371

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
6.09e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
(2S)-2-acetamido-3-(1H-imidazol-4-yl)propanoic acid

> <JCHEM_VEBER_RULE>
0

$$$$

HEADER    PROTEIN                                 06-MAR-20   NONE
TITLE     NULL                                                        
COMPND    NULL                                                        
SOURCE    NULL                                                        
KEYWDS    NULL                                                        
EXPDTA    NULL                                                        
AUTHOR    Marvin                                                      
REVDAT   1   06-MAR-20         0                                  
HETATM    1  C   UNK     0    8667.9238667.437   0.000  0.00  0.00           C+0
HETATM    2  C   UNK     0    8666.5908668.207   0.000  0.00  0.00           C+0
HETATM    3  N   UNK     0    8667.9238665.898   0.000  0.00  0.00           N+0
HETATM    4  C   UNK     0    8669.2568665.126   0.000  0.00  0.00           C+0
HETATM    5  C   UNK     0    8670.5928665.898   0.000  0.00  0.00           C+0
HETATM    6  O   UNK     0    8669.2568663.586   0.000  0.00  0.00           O+0
HETATM    7  C   UNK     0    8669.2568668.207   0.000  0.00  0.00           C+0
HETATM    8  O   UNK     0    8670.5928667.437   0.000  0.00  0.00           O+0
HETATM    9  O   UNK     0    8669.2568669.747   0.000  0.00  0.00           O+0
HETATM   10  N   UNK     0    8664.0028668.361   0.000  0.00  0.00           N+0
HETATM   11  C   UNK     0    8662.7568667.455   0.000  0.00  0.00           C+0
HETATM   12  N   UNK     0    8663.2328665.991   0.000  0.00  0.00           N+0
HETATM   13  C   UNK     0    8664.7728665.991   0.000  0.00  0.00           C+0
HETATM   14  C   UNK     0    8665.2488667.455   0.000  0.00  0.00           C+0
CONECT    1    2    3    7                                                  
CONECT    2    1   14                                                       
CONECT    3    1    4                                                       
CONECT    4    3    5    6                                                  
CONECT    5    4                                                            
CONECT    6    4                                                            
CONECT    7    1    8    9                                                  
CONECT    8    7                                                            
CONECT    9    7                                                            
CONECT   10   11   14                                                       
CONECT   11   10   12                                                       
CONECT   12   11   13                                                       
CONECT   13   14   12                                                       
CONECT   14   13   10    2                                                  
MASTER        0    0    0    0    0    0    0    0   14    0   28    0
END

View in JSmol View NMR Assignments View Stereo Labels

Synonyms

Value	Source
N-Acetyl histidine	ChEBI
N-alpha-L-Histidine	ChEBI
N-Hydroxy-aabp	ChEBI
N-a-L-Histidine	Generator
N-Α-L-histidine	Generator
N-Acetylhistidine, (DL)-isomer	HMDB
N-Acetylhistidine monohydrate	HMDB
(2S)-2-Acetamido-3-(1H-imidazol-5-yl)propanoic acid	HMDB
(2S)-2-Acetamido-3-(1H-imidazol-5-yl)propionic acid	HMDB
(S)-2-Acetamido-3-(1H-imidazol-4-yl)propanoicacid	HMDB
N-Acetyl-L-histidine	HMDB
N-alpha-Acetyl-L-histidine	HMDB
N-Α-acetyl-L-histidine	HMDB
N2-Acetylhistidine	HMDB
Nalpha-acetyl-L-histidine	HMDB
Nalpha-acetylhistidine	HMDB
Nα-acetyl-L-histidine	HMDB
Nα-acetylhistidine	HMDB
alpha-N-Acetyl-L-histidine	HMDB
Α-N-acetyl-L-histidine	HMDB
N-Acetylhistidine	ChEBI

Chemical Formula

C₈H₁₁N₃O₃

Average Molecular Weight

197.194

Monoisotopic Molecular Weight

197.080041226

IUPAC Name

(2S)-2-acetamido-3-(1H-imidazol-4-yl)propanoic acid

Traditional Name

(2S)-2-acetamido-3-(1H-imidazol-4-yl)propanoic acid

CAS Registry Number

2497-02-1

SMILES

CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O

InChI Identifier

InChI=1S/C8H11N3O3/c1-5(12)11-7(8(13)14)2-6-3-9-4-10-6/h3-4,7H,2H2,1H3,(H,9,10)(H,11,12)(H,13,14)/t7-/m0/s1

InChI Key

KBOJOGQFRVVWBH-ZETCQYMHSA-N

Chemical Taxonomy

Description

Belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.

Kingdom

Organic compounds

Super Class

Organic acids and derivatives

Class

Carboxylic acids and derivatives

Sub Class

Amino acids, peptides, and analogues

Direct Parent

Histidine and derivatives

Alternative Parents

Substituents

Histidine or derivatives
N-acyl-alpha amino acid or derivatives
N-acyl-alpha-amino acid
Imidazolyl carboxylic acid derivative
Azole
Imidazole
Heteroaromatic compound
Carboximidic acid
Carboximidic acid derivative
Carboxylic acid
Azacycle
Organoheterocyclic compound
Organic 1,3-dipolar compound
Propargyl-type 1,3-dipolar organic compound
Monocarboxylic acid or derivatives
Organic nitrogen compound
Organonitrogen compound
Organooxygen compound
Hydrocarbon derivative
Organic oxide
Organopnictogen compound
Organic oxygen compound
Carbonyl group
Aromatic heteromonocyclic compound

Molecular Framework

Aromatic heteromonocyclic compounds

External Descriptors

L-histidine derivative (CHEBI:16437 )
N-acetyl-L-amino acid (CHEBI:16437 )

Ontology

Physiological effect

Health effect

Digestive system disorder

Hepatobiliary disorder

Hepatic disorder

Liver damage (PMID: 31434538)

Nervous system disorder

Nerve damage (PMID: 31434538)

Disposition

Biological location

Organ

Placenta (HMDB: HMDB0032055)

Excreta

Biofluid or Excreta

Feces (PMID: 27543620)

Cellular substructure

Extracellular (HMDB: HMDB0032055)
Cytoplasm (HMDB: HMDB0032055)

Route of exposure

Enteral

Ingestion (HMDB: HMDB0032055)

Source

Endogenous

Endogenous (HMDB: HMDB0032055)

Animal

Animal (HMDB: HMDB0032055)

Exogenous

Food

Food (HMDB: HMDB0032055)

Milk and milk product

Unfermented milk

Milk (Cow) (FooDB: FOOD00618)

Aquatic origin

Fish

Fishes (FooDB: FOOD00865)

Exogenous (HMDB: HMDB0032055)

Process

Not Available

Role

Biological role

Waste product (PMID: 35448883)

Physical Properties

State

Solid

Experimental Molecular Properties

Property	Value	Reference
Melting Point	187 °C	Not Available
Boiling Point	620.20 °C. @ 760.00 mm Hg (est)	The Good Scents Company Information System
Water Solubility	11360 mg/L @ 25 °C (est)	The Good Scents Company Information System
LogP	-1.600 (est)	The Good Scents Company Information System

Experimental Chromatographic Properties

Not Available

Predicted Molecular Properties

Property	Value	Source
Water Solubility	6.09 g/L	ALOGPS
logP	-0.34	ALOGPS
logP	-2.5	ChemAxon
logS	-1.5	ALOGPS
pKa (Strongest Acidic)	3.53	ChemAxon
pKa (Strongest Basic)	6.55	ChemAxon
Physiological Charge	-1	ChemAxon
Hydrogen Acceptor Count	4	ChemAxon
Hydrogen Donor Count	3	ChemAxon
Polar Surface Area	95.08 Å²	ChemAxon
Rotatable Bond Count	4	ChemAxon
Refractivity	46.94 m³·mol⁻¹	ChemAxon
Polarizability	18.82 Å³	ChemAxon
Number of Rings	1	ChemAxon
Bioavailability	Yes	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted Chromatographic Properties

Predicted Collision Cross Sections

Predictor	Adduct Type	CCS Value (Å²)	Reference
DeepCCS	[M+H]+	137.137	30932474
DeepCCS	[M-H]-	134.742	30932474
DeepCCS	[M-2H]-	169.76	30932474
DeepCCS	[M+Na]+	144.67	30932474
AllCCS	[M+H]+	143.4	32859911
AllCCS	[M+H-H2O]+	139.5	32859911
AllCCS	[M+NH4]+	147.1	32859911
AllCCS	[M+Na]+	148.2	32859911
AllCCS	[M-H]-	141.0	32859911
AllCCS	[M+Na-2H]-	141.7	32859911
AllCCS	[M+HCOO]-	142.5	32859911

Predicted Retention Times

Underivatized

Chromatographic Method	Retention Time	Reference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.	2.25 minutes	32390414
Predicted by Siyang on May 30, 2022	9.4986 minutes	33406817
Predicted by Siyang using ReTip algorithm on June 8, 2022	7.38 minutes	32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid	357.3 seconds	40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid	441.8 seconds	40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid	283.9 seconds	40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid	43.7 seconds	40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid	164.9 seconds	40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid	62.5 seconds	40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid	288.3 seconds	40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid	228.8 seconds	40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)	826.6 seconds	40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid	579.6 seconds	40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid	41.8 seconds	40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid	721.1 seconds	40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid	182.8 seconds	40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid	275.6 seconds	40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate	556.2 seconds	40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA	510.6 seconds	40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water	364.2 seconds	40023050

Predicted Kovats Retention Indices

Underivatized

Metabolite	SMILES	Kovats RI Value	Column Type	Reference
N-Acetylhistidine	CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O	3051.0	Standard polar	33892256
N-Acetylhistidine	CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O	1875.1	Standard non polar	33892256
N-Acetylhistidine	CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O	2083.9	Semi standard non polar	33892256

Derivatized

Derivative Name / Structure	SMILES	Kovats RI Value	Column Type	Reference
N-Acetylhistidine,1TMS,isomer #1	CC(=O)N[C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C	1953.8	Semi standard non polar	33892256
N-Acetylhistidine,1TMS,isomer #2	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O)[Si](C)(C)C	1946.6	Semi standard non polar	33892256
N-Acetylhistidine,1TMS,isomer #3	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O	2077.9	Semi standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #1	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C)[Si](C)(C)C	1938.8	Semi standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #1	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C)[Si](C)(C)C	2014.9	Standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #2	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O[Si](C)(C)C	2113.2	Semi standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #2	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O[Si](C)(C)C	1951.4	Standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #3	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O)[Si](C)(C)C	2077.8	Semi standard non polar	33892256
N-Acetylhistidine,2TMS,isomer #3	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O)[Si](C)(C)C	2042.3	Standard non polar	33892256
N-Acetylhistidine,3TMS,isomer #1	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O[Si](C)(C)C)[Si](C)(C)C	2093.1	Semi standard non polar	33892256
N-Acetylhistidine,3TMS,isomer #1	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C)C=N1)C(=O)O[Si](C)(C)C)[Si](C)(C)C	2047.1	Standard non polar	33892256
N-Acetylhistidine,1TBDMS,isomer #1	CC(=O)N[C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C(C)(C)C	2187.3	Semi standard non polar	33892256
N-Acetylhistidine,1TBDMS,isomer #2	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O)[Si](C)(C)C(C)(C)C	2173.3	Semi standard non polar	33892256
N-Acetylhistidine,1TBDMS,isomer #3	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O	2343.2	Semi standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #1	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	2398.1	Semi standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #1	CC(=O)N([C@@H](CC1=C[NH]C=N1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	2464.8	Standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #2	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O[Si](C)(C)C(C)(C)C	2586.8	Semi standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #2	CC(=O)N[C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O[Si](C)(C)C(C)(C)C	2362.3	Standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #3	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O)[Si](C)(C)C(C)(C)C	2558.1	Semi standard non polar	33892256
N-Acetylhistidine,2TBDMS,isomer #3	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O)[Si](C)(C)C(C)(C)C	2436.2	Standard non polar	33892256
N-Acetylhistidine,3TBDMS,isomer #1	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	2744.9	Semi standard non polar	33892256
N-Acetylhistidine,3TBDMS,isomer #1	CC(=O)N([C@@H](CC1=CN([Si](C)(C)C(C)(C)C)C=N1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	2653.6	Standard non polar	33892256

Spectra

Biological Properties

Cellular Locations

Cytoplasm
Extracellular

Biospecimen Locations

Blood
Feces
Urine

Tissue Locations

Placenta

Pathways

Not Available

Name	SMPDB/PathBank	KEGG

Normal Concentrations

Biospecimen	Status	Value	Age	Sex	Condition	Reference	Details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	27543620	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	25037050	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	29808030	details
Urine	Detected and Quantified	8.13 (3.72-9.89) umol/mmol creatinine	Newborn (0-30 days old)	Both	Normal	Analysis of 40 NI...	details

Abnormal Concentrations

Biospecimen	Status	Value	Age	Sex	Condition	Reference	Details
Blood	Expected but not Quantified	Not Quantified	Not Specified	Not Specified	Cancer patients undergoing total body irradiation	31424920	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Colorectal cancer	27015276	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Colorectal cancer	25037050	details
Urine	Detected but not Quantified	Not Quantified	Not Specified	Not Specified	Cancer patients undergoing total body irradiation	31424920	details

Associated Disorders and Diseases

Disease References

Colorectal cancer

Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]

Associated OMIM IDs

114500 (Colorectal cancer)

External Links

DrugBank ID

Not Available

Phenol Explorer Compound ID

Not Available

FooDB ID

FDB008762

KNApSAcK ID

Not Available

Chemspider ID

68142

KEGG Compound ID

C02997

BioCyc ID

CPD-424

BiGG ID

Not Available

Wikipedia Link

Not Available

METLIN ID

Not Available

PubChem Compound

75619

PDB ID

Not Available

ChEBI ID

16437

Food Biomarker Ontology

Not Available

VMH ID

Not Available

MarkerDB ID

Not Available

Good Scents ID

rw1691611

References

Synthesis Reference

Not Available

Material Safety Data Sheet (MSDS)

Not Available

General References

Sass JO, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M, Loges NT, Schweitzer-Krantz S, Moebus R, Weiler P, Kispert A, Superti-Furga A, Wevers RA, Omran H: Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet. 2006 Mar;78(3):401-9. Epub 2006 Jan 18. [PubMed:16465618 ]
Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
Tanaka H, Sirich TL, Plummer NS, Weaver DS, Meyer TW: An Enlarged Profile of Uremic Solutes. PLoS One. 2015 Aug 28;10(8):e0135657. doi: 10.1371/journal.pone.0135657. eCollection 2015. [PubMed:26317986 ]
Van Damme P, Hole K, Pimenta-Marques A, Helsens K, Vandekerckhove J, Martinho RG, Gevaert K, Arnesen T: NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation. PLoS Genet. 2011 Jul;7(7):e1002169. doi: 10.1371/journal.pgen.1002169. Epub 2011 Jul 7. [PubMed:21750686 ]
Ree R, Varland S, Arnesen T: Spotlight on protein N-terminal acetylation. Exp Mol Med. 2018 Jul 27;50(7):1-13. doi: 10.1038/s12276-018-0116-z. [PubMed:30054468 ]
Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T: Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res. 2010 Sep;33(9):944-52. doi: 10.1038/hr.2010.113. Epub 2010 Jul 8. [PubMed:20613759 ]
Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J: A bench to bedside view of uremic toxins. J Am Soc Nephrol. 2008 May;19(5):863-70. doi: 10.1681/ASN.2007121377. Epub 2008 Feb 20. [PubMed:18287557 ]
(). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .

Showing metabocard for N-Acetylhistidine (HMDB0032055)

MOL for HMDB0032055 (N-Acetylhistidine)

3D MOL for HMDB0032055 (N-Acetylhistidine)

3D SDF for HMDB0032055 (N-Acetylhistidine)

3D-SDF for HMDB0032055 (N-Acetylhistidine)

PDB for HMDB0032055 (N-Acetylhistidine)

3D PDB for HMDB0032055 (N-Acetylhistidine)

SMILES for HMDB0032055 (N-Acetylhistidine)

INCHI for HMDB0032055 (N-Acetylhistidine)

Structure for HMDB0032055 (N-Acetylhistidine)

3D Structure for HMDB0032055 (N-Acetylhistidine)

Predicted Collision Cross Sections

Predicted Retention Times

Underivatized

Predicted Kovats Retention Indices

Underivatized

Derivatized